Financhill
Sell
36

CNVS Quote, Financials, Valuation and Earnings

Last price:
$3.54
Seasonality move :
14.58%
Day range:
$3.16 - $3.56
52-week range:
$0.72 - $4.19
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.14x
P/B ratio:
2.13x
Volume:
131.2K
Avg. volume:
396.8K
1-year change:
233.02%
Market cap:
$56M
Revenue:
$49.1M
EPS (TTM):
-$1.70
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Revenue $39.3M $31.4M $56.1M $68M $49.1M
Revenue Growth (YoY) -26.61% -20.04% 78.41% 21.36% -27.78%
 
Cost of Revenues $17.1M $16.1M $20.9M $36.4M $19.1M
Gross Profit $22.1M $15.3M $35.2M $31.7M $30M
Gross Profit Margin 56.36% 48.75% 62.73% 46.54% 61.06%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $16.3M $21.9M $26.6M $30.5M $23M
Other Inc / (Exp) -$2.8M -$45.7M $796K -$1.8M -$18.5M
Operating Expenses $26.5M $28.8M $34.1M $38.1M $31.7M
Operating Income -$4.3M -$13.5M $1M -$6.4M -$1.7M
 
Net Interest Expenses $7.2M $4.1M $356K $1.3M $1.1M
EBT. Incl. Unusual Items -$14.4M -$63.2M $1.5M -$9.6M -$21.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $313K -$315K -$788K $119K $10K
Net Income to Company -$14.7M -$62.9M $2.3M -$9.7M -$21.3M
 
Minority Interest in Earnings -$10K $85K -$59K -$39K -$142K
Net Income to Common Excl Extra Items -$14.7M -$62.8M $2.2M -$9.7M -$21.4M
 
Basic EPS (Cont. Ops) -$6.80 -$9.80 $0.21 -$1.13 -$1.78
Diluted EPS (Cont. Ops) -$6.80 -$9.80 $0.20 -$1.13 -$1.78
Weighted Average Basic Share $2.2M $6.4M $8.5M $8.9M $12.3M
Weighted Average Diluted Share $2.2M $6.4M $8.7M $8.9M $12.3M
 
EBITDA $2.2M -$52.2M $6.4M -$4.5M -$16.4M
EBIT -$7.2M -$59.1M $1.8M -$8.3M -$20.2M
 
Revenue (Reported) $39.3M $31.4M $56.1M $68M $49.1M
Operating Income (Reported) -$4.3M -$13.5M $1M -$6.4M -$1.7M
Operating Income (Adjusted) -$7.2M -$59.1M $1.8M -$8.3M -$20.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $7.2M $10.1M $14M $13M $12.7M
Revenue Growth (YoY) -29.87% 40.67% 38.63% -7.1% -2.1%
 
Cost of Revenues $4.3M $3.3M $8.1M $4.6M $6.3M
Gross Profit $2.9M $6.8M $5.9M $8.4M $6.5M
Gross Profit Margin 39.71% 67.01% 42.23% 64.3% 50.84%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $6.2M $7.2M $8.5M $5.7M $5.3M
Other Inc / (Exp) -$20.5M $768K -$564K -$692K $1K
Operating Expenses $7.9M $8.2M $10.6M $7.8M $7.3M
Operating Income -$5.1M -$1.4M -$4.7M $586K -$861K
 
Net Interest Expenses $1.2M $36K $380K $195K $337K
EBT. Incl. Unusual Items -$26.7M -$682K -$5.7M -$301K -$1.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$181K -$487K -- $16K $6K
Net Income to Company -$26.6M -$195K -$5.7M -$317K -$1.2M
 
Minority Interest in Earnings $23K $11K -$9K -$40K -$84K
Net Income to Common Excl Extra Items -$26.5M -$184K -$5.7M -$357K -$1.3M
 
Basic EPS (Cont. Ops) -$4.60 -$0.03 -$0.65 -$0.04 -$0.09
Diluted EPS (Cont. Ops) -$4.60 -$0.03 -$0.65 -$0.04 -$0.09
Weighted Average Basic Share $5.7M $8.4M $8.8M $12.4M $15.7M
Weighted Average Diluted Share $5.7M $8.4M $8.8M $12.4M $15.7M
 
EBITDA -$23.6M $490K -$4.3M $847K $114K
EBIT -$25.6M -$646K -$5.3M -$106K -$860K
 
Revenue (Reported) $7.2M $10.1M $14M $13M $12.7M
Operating Income (Reported) -$5.1M -$1.4M -$4.7M $586K -$861K
Operating Income (Adjusted) -$25.6M -$646K -$5.3M -$106K -$860K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $32.4M $43.3M $58.5M $66.4M $45M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $16.5M $17.1M $28.4M $32.5M $18.2M
Gross Profit $16M $26.3M $30.2M $33.9M $26.8M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $15.5M $25.1M $32M $25M $21.6M
Other Inc / (Exp) -$39.1M -$6.2M -$4.3M -$1.2M -$17.2M
Operating Expenses $24.2M $30.5M $39.8M $33.2M $29.9M
Operating Income -$8.2M -$4.2M -$9.6M $719K -$3.2M
 
Net Interest Expenses $5.6M $1.7M $689K $1.3M $1.3M
EBT. Incl. Unusual Items -$53M -$12.2M -$14.6M -$1.8M -$21.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $58K -$684K -$238K $155K -$13K
Net Income to Company -$53M -$11.5M -$14.4M -$1.9M -$21.7M
 
Minority Interest in Earnings $28K $52K -$90K -$66K -$196K
Net Income to Common Excl Extra Items -$53M -$11.4M -$14.5M -$2M -$21.9M
 
Basic EPS (Cont. Ops) -$11.40 -$0.83 -$1.79 -$0.21 -$1.70
Diluted EPS (Cont. Ops) -$11.40 -$0.83 -$1.79 -$0.21 -$1.70
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$38.9M -$4.9M -$10M $3.1M -$16.5M
EBIT -$47.3M -$10.4M -$13.9M -$483K -$20.3M
 
Revenue (Reported) $32.4M $43.3M $58.5M $66.4M $45M
Operating Income (Reported) -$8.2M -$4.2M -$9.6M $719K -$3.2M
Operating Income (Adjusted) -$47.3M -$10.4M -$13.9M -$483K -$20.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $13.2M $25.1M $27.6M $26M $21.9M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $7M $8M $15.4M $11.6M $10.7M
Gross Profit $6.2M $17.2M $12.1M $14.4M $11.1M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $10M $13.2M $17.3M $12.2M $10.9M
Other Inc / (Exp) -$36.5M $3.2M -$1.8M -$1.2M $167K
Operating Expenses $13.9M $15.7M $21.4M $16.5M $14.8M
Operating Income -$7.7M $1.4M -$9.3M -$2.1M -$3.6M
 
Net Interest Expenses $2.5M $180K $513K $490K $768K
EBT. Incl. Unusual Items -$46.6M $4.4M -$11.6M -$3.8M -$4.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$181K -$550K -- $36K $13K
Net Income to Company -$46.4M $5M -$11.6M -$3.9M -$4.3M
 
Minority Interest in Earnings $37K $4K -$27K -$54K -$107K
Net Income to Common Excl Extra Items -$46.4M $5M -$11.7M -$3.9M -$4.4M
 
Basic EPS (Cont. Ops) -$8.80 $0.57 -$1.34 -$0.41 -$0.29
Diluted EPS (Cont. Ops) -$8.80 $0.57 -$1.34 -$0.41 -$0.29
Weighted Average Basic Share $10.4M $16.8M $17.6M $22.3M $31.4M
Weighted Average Diluted Share $10.4M $17M $17.6M $22.3M $31.4M
 
EBITDA -$40.1M $7.3M -$9.1M -$1.6M -$1.6M
EBIT -$44.1M $4.6M -$11.1M -$3.3M -$3.5M
 
Revenue (Reported) $13.2M $25.1M $27.6M $26M $21.9M
Operating Income (Reported) -$7.7M $1.4M -$9.3M -$2.1M -$3.6M
Operating Income (Adjusted) -$44.1M $4.6M -$11.1M -$3.3M -$3.5M
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Cash and Equivalents $14.3M $16.8M $13.1M $7.2M $5.2M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $34.8M $21.1M $30.8M $20.8M $8.7M
Inventory $582K $166K $116K -- --
Prepaid Expenses $3.9M $2.7M $5M $3.7M $9.3M
Other Current Assets -- -- -- $1.7M $1.4M
Total Current Assets $57M $43.1M $52.2M $37.6M $32.7M
 
Property Plant And Equipment $9.2M $3.6M $2M $1.8M $2.3M
Long-Term Investments $23.4M $6.4M $7M $5.2M $362K
Goodwill $8.7M $8.7M $21.1M $20.8M $6.8M
Other Intangibles $6.9M $9.9M $20M $19.9M $18.3M
Other Long-Term Assets $5.2M $3.7M $2.3M $1.3M $1.3M
Total Assets $110.4M $75.4M $104.6M $88M $64.4M
 
Accounts Payable $50.7M $30.1M $34.2M $15M $5.8M
Accrued Expenses $5.1M $3.1M $3.9M $3.8M $4M
Current Portion Of Long-Term Debt $48.7M $9.7M -- -- --
Current Portion Of Capital Lease Obligations $593K $87K $258K $418K $401K
Other Current Liabilities -- -- $1.1M $1.4M $180K
Total Current Liabilities $128M $57.4M $57M $45.3M $31.2M
 
Long-Term Debt -- $2.2M -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $129.7M $59.6M $63.7M $48.9M $32.2M
 
Common Stock $3.6M $3.7M $3.7M $3.7M $3.8M
Other Common Equity Adj $92K -$68K -$163K -$402K -$345K
Common Equity -$21.6M $13.7M $38.7M $36.8M $29.7M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -$1.3M -$1.4M -$1.3M -$1.3M -$1.1M
Total Equity -$19.3M $15.9M $41M $39.1M $32.2M
 
Total Liabilities and Equity $110.4M $75.4M $104.6M $88M $64.4M
Cash and Short Terms $14.3M $16.8M $13.1M $7.2M $5.2M
Total Debt $48.7M $11.9M -- $4.9M $6.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $16.5M $12.6M $9.7M $8.6M $2.4M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $23.2M $24.2M $24.9M $12.4M $14.8M
Inventory $242K $122K $157K -- --
Prepaid Expenses $9.4M $3.6M $4.7M -- $10.8M
Other Current Assets -- -- -- $1.6M $2.1M
Total Current Assets $51.6M $42.6M $45.5M $34.5M $30.2M
 
Property Plant And Equipment $5.3M $2.6M $2.4M $2.1M $2.9M
Long-Term Investments $14.5M $7.4M $5.2M $4.5M --
Goodwill $8.7M $13.5M $21M $20.8M $6.8M
Other Intangibles $5.7M $16.4M $18.6M $19.1M $17.9M
Other Long-Term Assets $1M $1.4M $1.6M $1.1M $1.3M
Total Assets $86.8M $83.9M $94.3M $84.7M $60.6M
 
Accounts Payable -- -- $28.3M $8.1M $7.3M
Accrued Expenses -- -- $4.4M $3.3M $4.4M
Current Portion Of Long-Term Debt $28.4M -- -- -- --
Current Portion Of Capital Lease Obligations $135K $28K $127K $432K $273K
Other Current Liabilities -- $277K $741K $82K --
Total Current Liabilities $87.5M $53.7M $55.6M $35.2M $31.4M
 
Long-Term Debt $2.2M -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $89.8M $56.4M $62.4M $38.8M $31.8M
 
Common Stock $3.7M $3.7M $3.7M $3.8M $3.8M
Other Common Equity Adj -$18K -$87K -$477K -$414K -$297K
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -$1.3M -$1.4M -$1.3M -$1.2M -$1M
Total Equity -$3M $27.5M $31.9M $45.9M $28.8M
 
Total Liabilities and Equity $86.8M $83.9M $94.3M $84.7M $60.6M
Cash and Short Terms $16.5M $12.6M $9.7M $8.6M $2.4M
Total Debt $30.5M -- $3.6M $4.9M $7.8M
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Net Income to Stockholders -$14.7M -$62.9M $2.3M -$9.7M -$21.3M
Depreciation & Amoritzation $9.4M $6.9M $4.6M $3.8M $3.8M
Stock-Based Compensation $543K $2.9M $5.5M $4.5M $1.5M
Change in Accounts Receivable $311K $14.3M -$9.1M $10.3M $7.6M
Change in Inventories $495K $406K $50K -- --
Cash From Operations $7.8M -$20M $4.9M -$8.8M -$10.6M
 
Capital Expenditures $1.2M $2.6M $641K $1.3M $1.1M
Cash Acquisitions -- $815K -$11.7M -- --
Cash From Investing -$1.2M -$1.7M -$12.3M -$1.3M -$531K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- $2.2M -- $31M $44M
Long-Term Debt Repaid -$39.5M -$20.5M -$9.7M -$26M -$42.6M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$842K -$769K
Cash From Financing -$10.1M $24.3M $2.6M $4.2M $9.1M
 
Beginning Cash (CF) $18.9M $15.3M $17.8M $13.1M $7.2M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$3.6M $2.6M -$4.8M -$5.9M -$2M
Ending Cash (CF) $15.3M $17.8M $13.1M $7.2M $5.2M
 
Levered Free Cash Flow $6.5M -$22.6M $4.2M -$10.1M -$11.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$26.6M -$195K -$5.7M -$317K -$1.2M
Depreciation & Amoritzation $1.9M $1.1M $984K $953K $974K
Stock-Based Compensation $1M $946K $2.2M $500K $503K
Change in Accounts Receivable $3.1M $2.8M $182K $1.7M -$2.5M
Change in Inventories $776K $20K -- -- --
Cash From Operations -$9M $5.7M -$5.1M -$2.9M -$667K
 
Capital Expenditures $32K $40K $133K $243K $400K
Cash Acquisitions -- -$4M -$80K -- $204K
Cash From Investing $281K -$4M -$213K -$243K -$397K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- $3.6M $5M $11.6M
Long-Term Debt Repaid -$6.3M -$3M -$159K -$5M -$11.5M
Repurchase of Common Stock -- -- -- -- -$27K
Other Financing Activities -- -- -- -$386K -$537K
Cash From Financing $9M -$3.4M $3.5M -$352K -$462K
 
Beginning Cash (CF) $17.3M $14.4M $11.5M $12.1M $4M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $202K -$1.7M -$1.8M -$3.5M -$1.5M
Ending Cash (CF) $17.5M $12.6M $9.7M $8.6M $2.4M
 
Levered Free Cash Flow -$9.1M $5.7M -$5.2M -$3.2M -$1.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$53M -$11.5M -$14.4M -$1.9M -$21.7M
Depreciation & Amoritzation $8.5M $5.5M $3.9M $3.6M $3.8M
Stock-Based Compensation $1.6M $3.6M $6.8M $2.2M $1.6M
Change in Accounts Receivable $6.9M -$774K $83K $12.2M $575K
Change in Inventories $1.2M -$799K -- -- --
Cash From Operations -$8.8M $2.1M -$10.8M -$8.7M -$6.8M
 
Capital Expenditures $1.4M $2.6M $834K $1.5M $1.6M
Cash Acquisitions -- -$3.9M -$6.9M -- $204K
Cash From Investing -$458K -$7.3M -$7.8M -$1.5M -$836K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $2.2M -- $3.6M $41.2M $61M
Long-Term Debt Repaid -$39.6M -$14.3M -$2.4M -$39.4M -$58.3M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- -$1.1M
Cash From Financing $12.1M $337K $15.5M $9.1M $1.4M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $2.8M -$4.9M -$3M -$1.1M -$6.2M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$10.2M -$455K -$11.6M -$10.2M -$8.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$46.4M $5M -$11.6M -$3.9M -$4.3M
Depreciation & Amoritzation $4.1M $2.6M $2M $1.8M $1.8M
Stock-Based Compensation $1.2M $1.9M $3.2M $909K $973K
Change in Accounts Receivable $11.5M -$3.6M $5.6M $7.5M $478K
Change in Inventories $1.2M $44K -- -- --
Cash From Operations -$12.8M $9.4M -$6.3M -$6.2M -$2.4M
 
Capital Expenditures $111K $81K $274K $515K $1M
Cash Acquisitions -- -$4.8M -- -- $204K
Cash From Investing $789K -$4.8M -$274K -$515K -$820K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $2.2M -- $3.6M $13.8M $30.8M
Long-Term Debt Repaid -$14M -$7.8M -$443K -$13.8M -$29.5M
Repurchase of Common Stock -- -- -- -- -$215K
Other Financing Activities -- -- -- -$386K -$673K
Cash From Financing $14.2M -$9.7M $3.2M $8.2M $463K
 
Beginning Cash (CF) $32.6M $32.2M $24.6M $19.3M $9.1M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $2.2M -$5.2M -$3.4M $1.5M -$2.7M
Ending Cash (CF) $34.8M $27M $21.2M $20.7M $6.4M
 
Levered Free Cash Flow -$12.9M $9.3M -$6.6M -$6.7M -$3.4M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock